English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Glaxo Smith Kline
Bree Gonzales
| Feb 2, 2022
Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Trending
+
Pharmaceuticals
Patient Daily
| Feb 19, 2025
American Lung Association hosts Fight For Air Climb in Los Angeles
+
Pharmaceuticals
Patient Daily
| Feb 18, 2025
South Florida firefighter aims to defeat lung disease through annual stair climb
+
Pharmaceuticals
Patient Daily
| Feb 18, 2025
Expert tips for managing springtime allergies effectively
+
Regulatory
Patient Daily
| Feb 14, 2025
Spokesperson for Patients Come First: 340B program is ‘one of the most blatant abuses of a governmental program’
